Press release
Embolotherapy Market Revenue to Reach US$ 5,758.28 Million by 2028
The embolotherapy market is expected to grow from US$ 3,341.49 million in 2021 to US$ 5,758.28 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2022 to 2028.According to our new research study on "Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product, Disease Indication, Procedure, and End User," the market is expected to grow from US$ 3,341.49 million in 2021 to US$ 5,758.28 million by 2028. It is estimated to grow at a CAGR of 8.1% during 2022-2028.
Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPRE00006432/?utm_source=OpenPR&utm_medium=10381
Factors driving the growth of the embolotherapy market are rising incidence of cancer cases, rising patient preference for minimally invasive procedures, and increasing incidence of hypertension, obesity, smoking, and alcoholism. The availability of alternative therapies and the high cost of embolization agents hinder the overall market growth.
Key Players : Abbott Laboratories, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson Consumer Inc., Medtronic, Acandis GmbH, Terumo Corporation, Balt USA LLC, Stryker Corporation, and Guerbet LLC are among the leading companies operating in the embolotherapy market.
Based on disease indication, the embolotherapy market is segmented into cancer, peripheral vascular disease, neurological disease, urological and nephrological disorder, gastrointestinal disorder, and other. In 2021, the cancer segment accounted for the largest share of the market. Moreover, the same segment is anticipated to grow at the fastest rate during the forecast period. Embolization has become the accepted treatment modality in patients with many clinical scenarios. Embolization treats cancers such as neuroendocrine tumors, renal cell carcinoma, and hepatocellular carcinoma. The goal of embolization in cancer treatment is usually to cause ischemia within the tumor, which leads to tumor necrosis. This effect may be enhanced by adding a chemotherapeutic drug to the embolic substance which is referred chemoembolization. Another aim of embolization in cancer treatment is to remove a tumor that cannot be removed surgically because it is situated deep in the body. Thus, embolotherapy is rapidly becoming a preferred treatment for cancer as it cuts the tumor from the blood supply, starving it of nutrients. In addition, rising incidences of cancer worldwide coupled with the respective adoption of Transarterial chemoembolization (TACE) and Transcatheter Arterial Radioembolization (TARE) procedures is likely to spur the market growth during the forecast period.
Buy Report @ https://www.theinsightpartners.com/buy/TIPRE00006432/?utm_source=OpenPR&utm_medium=10381
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Embolotherapy Market Revenue to Reach US$ 5,758.28 Million by 2028 here
News-ID: 3423465 • Views: …
More Releases from The Insight Partners
Thrust Vector Control - Key Industry Dynamics
Thrust Vector Control analysis By Technology (Gimbal Nozzle, Thrusters, Flex Nozzle, Rotating Nozzle); Application (Launch Vehicles, Satellites, Fighter Crafts, Missiles); End User (Defense, Space-agencies)
Download PDF:- https://www.theinsightpartners.com/sample/TIPRE00010092?utm_source=Openpr&utm_medium=10413
Market leaders and key company profiles
Almatech
BAE Systems
Honeywell International Inc.
JASC (Jansen's Aircraft Systems Controls, Inc.)
Moog, Inc.
Raytheon Technologies Corporation
PARKER HANNIFIN CORP
Sierra Nevada Corporation
SABCA (Sociétés Anonyme Belge de Constructions Aéronautiques)
Thrust Vector Control Market Segmentation
Technology
Gimbal Nozzle
Thrusters
Flex Nozzle
Rotating Nozzle
Application
Launch Vehicles
Satellites
Fighter Crafts
Missiles
End User
Defense
Space-agencies
Contact Us
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com
Phone: +1-646-491-9876
About The Insight Partners
The Insight…
Commercial Rainscreen Cladding Market Growth is expected at CAGR of 18.5% during …
Global Commercial Rainscreen Cladding Market 2030 Report give our customers an exhaustive and top to bottom examination of Commercial Rainscreen Cladding Market alongside its key factors, for example, market diagram and rundown, pieces of the pie, restrictions, drivers, local examination, players, serious elements, division, and considerably more. The Commercial Rainscreen Cladding Market information introduced inside this report is acquired dependent on a few strategies, for example, PESTLE, Porter's Five, SWOT…
Geothermal Power Generation Market to Reach US$ 27.15 Billion by 2031, Driven by …
New York, US - October 28, 2025 - According to the latest market study by The Insight Partners, the Geothermal Power Generation Market is projected to grow from US$ 15,453.3 million in 2023 to US$ 27,149.2 million by 2031, registering a robust CAGR of 7.3% during the forecast period (2023-2031). The increasing focus on renewable energy, low greenhouse gas emissions, and the rising role of geothermal power in the global…
Aircraft Thrust Reverser Actuation Systems - A Complete Guide
Aircraft Thrust Reverser Actuation Systems analysis By Aircraft Type (Commercial, Military, General Aviation); Product (Cascade, Pivot, Bucket); Manufacturing Process (Hand Layup, ATL/AFP, Resin Infusion); Mechanism (Hydraulics, Electrical)
Download PDF:- https://www.theinsightpartners.com/sample/TIPRE00018335?utm_source=Openpr&utm_medium=10413
Market leaders and key company profiles
Arkwin Industries, Inc.
Collins Aerospace, a Raytheon Technologies company
Diakont
Honeywell International
Middle River Aerostructure Systems
PARKER HANNIFIN CORP
Safran
Spirit AeroSystems, Inc.
Triumph Group
Aircraft Thrust Reverser Actuation Systems Market Segmentation
Aircraft Type
Commercial
Military
General Aviation
Product
Cascade
Pivot
Bucket
Manufacturing Process
Hand Layup
ATL/AFP
Resin Infusion
Mechanism
Hydraulics
Electrical
Contact Us
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com
Phone: +1-646-491-9876
About The Insight Partners
The Insight Partners…
More Releases for Embolotherapy
Embolotherapy Market Size Expected to Hit $10.68 Billion by 2032
According to Value Market Research, the global Embolotherapy Market size is anticipated to experience significant growth, with expectations to reach nearly USD 10.68 billion by 2032, up from USD 4.87 billion in 2023. This growth corresponds to a robust compound annual growth rate (CAGR) of 9.12% during the forecast period from 2024 to 2032. The expansion of the market is attributed to advancements in embolotherapy technologies, increasing prevalence of chronic…
Embolotherapy Market Future Prediction Report By 2031
Embolotherapy Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.
Request Sample…
Embolotherapy Market 2023 Size, Share, Growth Report 2030
Latest Updated Report 2023, The Global Embolotherapy Market to Growing A CAGR of % during forecast period of 2023-2030. The Market is segmented by Global Embolotherapy Market Breakdown by Application (Hospitals and Clinics, Ambulatory Surgical Centers, Other End Users) by Type (Embolic Agents, Microspheres, Embolic Coils, Liquid Embolic Agents, Embolic Plug Systems, Detachable Balloons, Support Devices, Microcatheters, Guidewires) and by Geography (North America, South America, Europe, Asia Pacific, MEA).
The Embolotherapy…
Embolotherapy Market Growth, Development and Demand Forecast Report, 2030
The National Cancer Institute, under the U.S. Department of Health and Human Services, states that 76,080 new cases of kidney and renal pelvic cancer were diagnosed in the U.S. in 2021. Further, the Brain Aneurysm Foundation estimates that over 30,000 people suffer a brain aneurysm rupture every year in the U.S. Likewise, Brain Foundation of Migraine and Headache Australia states that approximately more than 2% of adults suffer from aneurysms…
Embolotherapy Market 2022 - 2028 Worldwide Major Industry Players' Review
The "Global Embolotherapy Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Embolotherapy Market with detailed market segmentation by type, application, end user and geography. The global Embolotherapy Market is expected to witness high growth during the forecast period. The report provides key statistics on the…
Embolotherapy Market To Generate $6,447.1 Million Revenue by 2030
A number of factors, such as the rising incidence of lifestyle-associated and chronic illnesses, growing aging population, surging patient pool, increasing healthcare spending, growing medical tourism industry, and enhancing healthcare infrastructure, are projected to propel the growth of the embolotherapy market at CAGR of 7.7% during the forecast period (2020–2030). According to P&S Intelligence, the market size is expected to reach $6,447.1 million by 2030 from $3,082.9 million in 2020.…
